Growth Hormone Deficiency in Children (DBCOND0034025)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT04970654	A Research Study in Chinese Children With a Low Level of Hormone to Grow. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day.	Somapacitan Somatotropin	treatment	3	completed
NCT01514500	First Human Dose Trial of NNC0195-0092 (Somapacitan) in Healthy Subjects	No drug interventions	treatment	1	completed
NCT03672617	Validation of a Questionnaire That Identifies the Reasons for Non-adherence to Existing Growth Hormone Therapy	No drug interventions	Not Available	Not Available	completed
NCT01327924	Usability and Tolerability of the Norditropin NordiFlex® Injection Device in Children Never Previously Treated With Growth Hormone	No drug interventions	Not Available	Not Available	completed
NCT06109935	Special Use-results Surveillance on Long Term Use of Sogroya® in Children With Short Stature Due to Growth Hormone Deficiency Where Epiphysial Discs Are Not Closed	Somapacitan	Not Available	Not Available	enrolling_by_invitation
NCT01068639	An Observational Study on Treatment Compliance by Children Treated With Growth Hormone	No drug interventions	Not Available	Not Available	withdrawn
NCT02616562	Investigating Efficacy and Safety of Once-weekly NNC0195-0092 (Somapacitan) Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency	No drug interventions	treatment	2	recruiting
NCT00936403	A Single Dose Trial in Growth Hormone Deficient Children Investigating Safety, Pharmacokinetics and Pharmacodynamics of Long Acting Growth Hormone	No drug interventions	treatment	2	completed
NCT03972345	Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)	No drug interventions	Not Available	Not Available	enrolling_by_invitation
NCT01604161	Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome	No drug interventions	Not Available	Not Available	completed
NCT00960128	Observational Prospective Study on Patients Treated With Norditropin®	No drug interventions	Not Available	Not Available	completed
NCT00567385	Liquid Somatropin Formulation in Children With Growth Hormone Deficiency	No drug interventions	treatment	4	completed
NCT02580032	Validation of Two Measures for Growth Hormone Deficiency in Children, the Treatment Related Impact Measure of Childhood Growth Hormone Deficiency (TRIM-CGHD) and the Treatment Burden Measure of Childhood Growth Hormone Deficiency (TB-CGHD)	No drug interventions	Not Available	Not Available	completed
NCT00262249	Effect of Growth Hormone in Children With Growth Hormone Deficiency	Somatotropin	treatment	3	completed
NCT01502124	Safety and Efficacy of Somatropin in Children With Growth Hormone Deficiency	No drug interventions	treatment	3	completed
NCT03811535	A Research Study in Children With a Low Level of Hormone to Grow. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day (REAL4)	No drug interventions	treatment	3	active_not_recruiting
NCT01500486	Observational Study of Norditropin NordiFlex® With NordiFlex PenMate™	No drug interventions	Not Available	Not Available	completed
NCT01563926	Evaluating Acceptance of New Liquid Somatropin Formulation in Children With Growth Hormone Deficiency	No drug interventions	treatment	3	completed
NCT01245374	Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents	No drug interventions	treatment	4	completed
NCT03212131	Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Mild and Moderate Degrees of Hepatic Impairment Compared to Subjects With Normal Hepatic Function.	No drug interventions	treatment	1	completed
NCT01973244	A Trial Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Dose of Long-acting Growth Hormone (Somapacitan) Compared to Daily Dosing of Norditropin® SimpleXx® in Children With Growth Hormone Deficiency	No drug interventions	treatment	1	completed
NCT01543867	Safety and Efficacy of Long-term Somatropin Treatment in Children	No drug interventions	Not Available	Not Available	completed
NCT03186495	Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Various Degrees of Impaired Renal Function Compared to Subjects With Normal Renal Function	No drug interventions	treatment	1	completed